admiss
cxr
girl
sar
show
airspac
opac
illdefin
border
middl
lower
zone
left
lung
sever
acut
respiratori
syndrom
sar
newli
describ
infecti
diseas
caus
novel
sarsassoci
coronaviru
sarscov
becom
major
threat
public
health
global
sar
highli
contagi
aptli
coin
first
plagu
twentyfirst
centuri
diseas
characteris
transmiss
healthcar
household
set
intrigu
superspread
event
pivot
global
spread
superspread
event
includ
major
hospit
outbreak
inflight
transmiss
board
commerci
paediatr
respiratori
review
summari
children
suscept
infect
sarsassoci
coronaviru
sarscov
clinic
pictur
sar
milder
adult
teenag
resembl
adult
present
diseas
progress
may
develop
sever
ill
requir
intens
care
assist
ventil
fever
malais
cough
coryza
chill
rigor
sputum
product
headach
myalgia
leucopaenia
lymphopaenia
thrombocytopaenia
mildli
prolong
activ
partial
thromboplastin
time
elev
lactat
dehydrogenas
level
common
present
featur
radiograph
find
nonspecif
highresolut
comput
tomographi
thorax
clinic
suspect
case
may
earli
diagnost
aid
initi
chest
radiograph
appear
normal
improv
revers
transcriptionpolymeras
chain
reaction
rtpcr
assay
critic
earli
diagnosi
sar
sensit
approach
first
day
ill
perform
nasopharyng
aspir
prefer
specimen
absenc
seroconvers
sarscov
beyond
day
diseas
onset
gener
exclud
diagnosi
best
treatment
strategi
sar
among
children
remain
determin
case
fatal
report
children
shortto
mediumterm
outcom
appear
good
import
continu
monitor
longterm
complic
due
diseas
empir
treatment
overemphasis
elsevi
ltd
right
reserv
abbrevi
sar
sever
acut
respiratori
syndrom
sarscov
sarsassoci
coronaviru
rsv
respiratori
syncyti
viru
ard
acut
respiratori
distress
syndrom
cxr
chest
radiograph
hrct
highresolut
comput
tomographi
boop
bronchiol
obliteransorganis
pneumonia
npa
nasopharyng
aspir
rtpcr
revers
transcriptionpolymeras
chain
reaction
ifa
immunofluoresc
assay
elisa
enzymelink
immunosorb
assay
correspond
cw
leung
email
leungcw
haorghk
airlin
transmiss
hotel
largescal
commun
outbreak
dens
popul
residenti
complex
primarili
result
environment
contamin
superspread
diarrhoea
well
describ
diseas
first
start
mysteri
outbreak
atyp
pneumonia
guangdong
provinc
southern
china
novemb
juli
countri
region
world
affect
sar
worldwid
total
case
probabl
sar
healthcar
worker
death
record
hong
kong
toll
affect
individu
includ
healthcar
worker
death
subsequ
reemerg
first
six
sporad
case
sar
two
probabl
laboratoryacquir
result
local
transmiss
singapor
taiwan
china
children
appear
less
affect
diseas
smaller
case
number
less
sever
ill
report
age
group
suscept
sarscov
new
human
howev
rapid
isol
diseas
adult
whose
infect
lower
first
day
ill
contribut
reduc
frequenc
household
exposur
children
exact
number
children
affect
sar
worldwid
unknown
age
breakdown
report
case
avail
incomplet
affect
countri
sar
surveil
team
person
commun
estim
children
year
age
account
total
affect
report
mortal
children
sar
surveil
team
person
commun
total
children
age
year
regist
esar
databas
hospit
author
hong
kong
account
patient
notifi
crude
agespecif
attack
rate
children
hong
kong
per
person
year
age
serolog
confirm
sar
document
children
per
person
year
age
sixtyfour
children
clinic
diseas
seroconvers
sarscov
manag
author
hospit
experi
cohort
laboratoryconfirm
patient
form
basi
clinic
inform
present
review
children
report
worldwid
previous
healthi
sex
predomin
thirtyf
children
manag
author
girl
male
femal
ratio
mean
median
age
year
respect
youngest
patient
prematur
infant
youngest
case
report
date
comorbid
present
children
none
immunocompromis
epidemiolog
link
avail
vast
major
children
sar
appear
import
clue
lead
diagnosi
epidem
situat
worldwid
children
usual
secondari
household
contact
affect
adult
healthcar
worker
intern
travel
return
area
local
transmiss
sar
transmiss
among
children
children
adult
contact
uncommon
serolog
confirm
children
hong
kong
victim
point
sourc
commun
outbreak
due
environment
contamin
actual
proport
children
secondari
household
contact
particular
outbreak
could
determin
given
short
incub
period
exposur
either
common
environment
sourc
index
household
member
present
publish
report
differ
suscept
communic
children
adult
appar
differ
might
relat
differ
risk
exposur
two
age
group
sar
larg
atyp
pneumonia
minim
extrapulmonari
manifest
apart
diarrhoea
cellular
tropism
sarscov
demonstr
primarili
pneumocyt
surfac
enterocyt
small
bowel
clinic
present
sar
nonspecif
featur
overlap
atyp
pneumonia
caus
respiratori
pathogen
influenza
viru
includ
highli
pathogen
avian
influenza
virus
parainfluenza
viru
adenoviru
respiratori
syncyti
viru
rsv
mycoplasma
pneumonia
chlamydia
pneumonia
chlamydia
psittaci
legionella
pneumophila
clinic
cours
sar
adult
patient
well
describ
appear
follow
triphas
pattern
follow
incub
period
day
mean
day
ci
adult
present
prodrom
characteris
high
fever
temperatur
chill
rigor
malais
headach
dizzi
myalgia
upper
respiratori
symptom
coryza
sore
throat
mild
uncommon
diarrhoea
present
featur
adult
patient
day
diseas
progress
involv
lower
respiratori
tract
dri
nonproduct
cough
dyspnoea
becom
promin
case
progress
acut
respiratori
distress
syndrom
ard
necessit
intub
assist
ventil
observ
mortal
result
primarili
respiratori
failur
signific
proport
patient
recov
pulmonari
destruct
extend
period
sar
appear
run
less
aggress
clinic
cours
children
compar
adult
sever
ill
vari
extent
asymptomat
infect
unknown
although
believ
uncommon
children
usual
hospitalis
day
onset
symptom
one
paediatr
case
seri
mean
durat
fever
admiss
ae
day
median
rang
common
present
clinic
featur
children
includ
fever
malais
cough
coryza
chill
rigor
sputum
product
headach
myalgia
tabl
lethargi
poor
feed
anorexia
nausea
vomit
diarrhoea
abdomin
pain
sore
throat
dyspnoea
dizzi
less
commonli
encount
less
children
may
pass
loos
wateri
stool
profus
diarrhoea
rare
throughout
cours
ill
blood
mucu
stool
featur
suggest
inflammatori
enterocol
report
cough
predominantli
unproduct
natur
found
half
children
present
definit
physic
sign
consolid
hardli
evid
crepit
crackl
chest
auscult
unusu
despit
promin
radiograph
evid
pulmonari
infiltr
even
patient
develop
respiratori
distress
henc
descript
atyp
pneumonia
lymphadenopathi
hepatosplenomegali
clinic
bleed
absent
skin
rash
exceedingli
rare
manifest
hypoxaemia
seldom
note
present
gener
develop
toward
end
first
week
begin
second
week
ill
sever
case
youngest
patient
howev
present
cyanot
attack
dyspnoea
cough
hypothermia
subsequ
develop
fever
teenag
age
year
may
resembl
adult
present
diseas
progress
tend
constitut
upset
system
symptom
malais
chill
rigor
headach
myalgia
dizzi
significantli
common
tabl
appear
sicker
greater
need
oxygen
therapi
respiratori
support
may
requir
intens
care
children
year
age
gener
milder
symptom
coryza
significantli
common
tabl
appear
run
milder
shorter
clinic
cours
clinic
pictur
sometim
indistinguish
viral
infect
upper
respiratori
tract
thu
pose
diagnost
challeng
clinic
cours
sar
major
children
follow
biphas
pattern
phase
viral
replic
last
day
characteris
abrupt
onset
fever
constitut
symptom
associ
increas
bodi
viral
load
phase
immunopatholog
damag
mark
progress
pneumonia
hypoxaemia
bodi
viral
load
declin
exagger
host
immun
respons
superven
prodrom
pneumon
phase
diseas
howev
may
less
distinct
comparison
adult
patient
progress
ard
third
phase
adult
seen
small
number
children
predominantli
adolesc
natur
histori
untreat
sar
adult
children
remain
unclear
patient
worldwid
receiv
form
empir
treatment
form
antivir
agent
without
corticosteroid
probabl
spontan
recoveri
could
ascertain
nevertheless
three
children
mild
diseas
recov
support
therapi
alon
author
cohort
anecdot
report
extrapulmonari
manifest
sar
form
central
nervou
system
dysfunct
probabl
viral
hepat
describ
adult
atyp
present
sar
form
nonspecif
febril
ill
febril
nonpneumon
respiratori
ill
observ
children
adult
case
like
evad
clinic
detect
absenc
definit
contact
histori
patient
suspect
confirm
sar
full
spectrum
clinic
well
subclin
ill
caus
infect
sarscov
unfold
epidemiolog
studi
case
report
sar
basic
pneumon
infect
chest
radiograph
cxr
therefor
essenti
diagnost
tool
princip
radiograph
abnorm
sar
children
illdefin
airspac
shadow
present
groundglass
opac
andor
unifoc
lobar
multifoc
area
consolid
unilater
focal
opac
report
common
find
one
paediatr
case
seri
evid
children
present
fig
adult
region
airspac
diseas
predomin
lower
lobe
also
note
elsewher
appear
predomin
distribut
pattern
consolid
children
cxr
opac
often
peripher
mix
central
peripher
locat
lung
opac
show
tendenc
progress
increas
size
involv
multipl
area
either
unilater
bilater
moder
sever
case
rapid
progress
unilater
multifoc
bilater
involv
reduct
lung
volum
second
week
ill
typic
children
develop
sever
hypoxaemia
fig
advanc
stage
diseas
occur
small
number
children
widespread
groundglass
opac
diffus
patchi
consolid
seen
like
repres
progress
ard
pneumon
chang
may
appar
present
mildli
symptomat
individu
may
identifi
earli
prodrom
period
contact
trace
patient
diagnos
sar
repeat
cxr
examin
guid
failur
resolut
symptom
chang
clinic
condit
clarifi
pictur
reveal
new
pulmonari
infiltr
diseas
progress
frequent
monitor
cxr
chang
addit
benefit
detect
earli
radiograph
deterior
mani
patient
herald
clinic
deterior
radiograph
resolut
hand
gener
lag
behind
clinic
improv
complet
resolut
airspac
opac
take
month
sever
affect
children
preliminari
evid
pulmonari
fibrosi
bronchial
wall
thicken
bronchiectasi
lung
volum
loss
observ
followup
one
paediatr
case
seri
viral
pneumonia
tend
show
reticulonodular
well
symmetr
perihilar
peribronchi
pattern
infiltr
sometim
mark
hilar
adenopathi
contrast
pneumonia
caus
respiratori
pathogen
cxr
children
sar
show
evid
interstiti
diseas
hilar
adenopathi
mediastin
widen
signific
pleural
effus
cavit
abscess
format
pneumatocel
pneumothorax
pneumomediastinum
nevertheless
radiograph
featur
sar
children
nonspecif
radiolog
differenti
sar
commonli
encount
childhood
respiratori
ill
caus
airspac
diseas
difficult
highresolut
comput
tomographi
hrct
chest
use
earli
diagnost
tool
clinic
suspect
children
initi
neg
equivoc
chest
radiograph
hrct
find
may
includ
groundglass
opacif
unifoc
multifoc
consolid
subpleur
peripher
central
region
interlobular
septal
intralobular
interstiti
thicken
fig
characterist
peripher
alveolar
opac
reminisc
bronchiol
obliteransorganis
pneumonia
boop
gener
hrct
sensit
detect
extens
airspac
consolid
groundglass
attenu
cxr
investig
particularli
use
lung
parenchym
abnorm
minim
earli
cours
ill
obscur
diaphragm
cardiac
silhouett
util
chest
hrct
lie
earli
confirm
airspac
diseas
radiograph
inappar
case
strong
contact
histori
clinic
featur
highli
suspici
sar
thu
allow
prompt
isol
monitor
clinic
radiolog
deterior
haematolog
biochem
abnorm
sar
children
neither
diagnost
specif
like
adult
consist
haematolog
find
lymphopaenia
present
children
present
cours
ill
deplet
lymphocyt
may
secondari
direct
cytopath
effect
viru
cytokinemedi
apoptosi
lymphocyt
margin
due
increas
cortisol
secret
activ
hypothalamicpituitaryadren
axi
administr
highdos
glucocorticoid
profound
lympholyt
effect
especi
lymphocyt
haematolog
abnorm
leucopaenia
thrombocytopaenia
mildli
prolong
activ
partial
thromboplastin
time
observ
children
anaemia
rare
found
present
detect
children
unlik
adult
signific
drop
haemoglobin
level
cours
ill
necessit
discontinu
empir
antivir
therapi
name
ribavirin
observ
reactiv
thrombocytosi
recoveri
sar
significantli
common
children
year
age
phenomenon
sometim
observ
children
recov
system
viral
infect
probabl
relat
use
corticosteroid
despit
abnorm
clot
profil
elev
ddimer
level
detect
lupu
anticoagul
small
number
children
bleed
event
thrombot
complic
report
common
biochem
abnorm
children
sar
elev
lactat
dehydrogenas
level
present
present
cours
ill
elev
alanin
aminotransferas
level
seen
children
present
cours
ill
elev
creatin
kinas
level
vari
case
seri
teenag
patient
tend
derang
laboratori
paramet
may
take
longer
resolv
similar
human
infect
avian
influenza
viru
cytokin
dysregul
believ
pivot
immunopathogenesi
sar
among
adult
children
serial
monitor
plasma
inflammatori
cytokin
profil
use
flow
cytometri
cohort
eight
paediatr
patient
suggest
pathway
infect
macrophag
select
activ
reflect
substanti
elev
circul
level
convers
tumour
necrosi
factora
level
markedli
increas
human
infect
avian
influenza
viru
overtli
elev
throughout
cours
ill
predomin
activ
immun
respons
facilit
viral
clearanc
may
explain
rapid
recoveri
children
sar
newli
emerg
infecti
diseas
unknown
aetiolog
initi
initi
case
definit
suspect
probabl
sar
promulg
world
health
organ
meant
surveil
necessarili
broadli
inclus
nonspecif
patient
categoris
base
clinic
radiolog
epidemiolog
featur
exclus
altern
diagnos
origin
surveil
case
definit
sar
requir
lower
respiratori
symptom
cough
short
breath
difficulti
breath
present
appli
would
miss
mani
children
present
symptom
lack
sensit
specif
initi
case
definit
gener
uncertainti
individu
case
manag
point
care
understand
diseas
identif
novel
coronaviru
caus
agent
case
definit
sar
revis
may
clinic
radiolog
featur
nonspecif
much
emphasi
place
identif
epidemiolog
link
suggest
diagnosi
vast
major
patient
last
epidem
clear
histori
exposur
either
patient
suspect
diagnos
sar
set
recent
local
transmiss
occur
epidem
epidemiolog
clue
becam
difficult
ascertain
sporad
case
reemerg
latest
case
definit
postoutbreak
period
incorpor
clinic
laboratori
element
emphasi
clearli
defin
microbiolog
criteria
besid
exclus
altern
diagnos
tabl
nevertheless
care
epidemiolog
histori
take
remain
essenti
diagnost
workup
earli
implement
appropri
infect
control
measur
suspect
patient
import
question
ask
peac
time
includ
histori
recent
travel
previous
sarsaffect
area
area
increas
likelihood
anim
human
transmiss
sarscov
infect
close
contact
suspect
sar
patient
histori
recent
hospitalis
contact
healthcar
facil
individu
either
healthcar
worker
laboratori
worker
potenti
exposur
sar
patient
live
sarscov
link
cluster
case
unexplain
respiratori
ill
commun
microbiolog
investig
cornerston
confirm
sar
diagnost
workup
includ
test
pathogen
caus
communityacquir
pneumonia
children
blood
cultur
also
need
children
product
cough
old
enough
produc
reliabl
specimen
sputum
bacteri
cultur
perform
nasopharyng
aspir
npa
save
rapid
antigen
detect
influenza
b
rsv
adenoviru
parainfluenza
type
use
direct
immunofluoresc
assay
urin
sampl
may
test
legionella
pneumophila
streptococcu
pneumonia
antigen
npa
specimen
also
inocul
differ
cell
line
isol
respiratori
virus
serolog
studi
includ
mycoplasma
pneumonia
igm
pair
acut
convalesc
sera
igg
mycoplasma
pneumonia
chlamydia
pneumonia
chlamydia
psittaci
legionella
pneumophila
influenza
b
rsv
adenoviru
parainfluenza
type
specif
test
detect
sarscov
includ
molecular
nucleic
acid
amplif
test
use
revers
transcriptionpolymeras
chain
reaction
rtpcr
antibodi
test
cell
cultur
view
high
transmiss
sar
hospit
laboratori
confirm
diagnosi
earli
cours
ill
vital
allow
best
utilis
limit
isol
cohort
facil
hospit
rapid
diagnosi
rtpcr
test
target
specif
segment
sarscov
genom
primarili
polymeras
gene
use
extens
last
epidem
method
appli
nasopharyng
aspir
nose
throat
swab
saliva
sputum
endotrach
aspir
bronchoalveolar
lavag
stool
urin
plasma
serum
nasopharyng
aspir
combin
nose
throat
swab
stool
commonli
use
experi
hong
kong
toronto
suggest
first
gener
convent
rtpcr
assay
use
time
initi
outbreak
lack
suffici
sensit
clinic
rule
sar
despit
initi
optim
test
sensit
npa
combin
nose
throat
swab
stool
first
day
ill
reach
maximum
sensit
perform
upper
respiratori
specimen
collect
day
onset
fever
govern
viru
unit
public
health
laboratori
centr
hong
kong
special
administr
region
data
file
day
coincid
maximum
viral
load
npa
specimen
clinic
pictur
diagnosi
treatment
outcom
sar
children
person
histori
fever
one
symptom
lower
respiratori
tract
ill
cough
difficulti
breath
short
breath
radiograph
evid
lung
infiltr
consist
pneumonia
rd
autopsi
find
consist
patholog
pneumonia
rd
without
identifi
caus
altern
diagnosi
fulli
explain
ill
laboratori
definit
sar
person
symptom
sign
clinic
suggest
sar
posit
laboratori
find
sarscov
base
one
follow
diagnost
criteria
pcr
posit
sarscov
use
valid
method
least
two
differ
clinic
specimen
eg
nasopharyng
stool
clinic
specimen
collect
two
occas
cours
ill
eg
sequenti
nasopharyng
aspir
two
differ
assay
repeat
pcr
use
new
rna
extract
origin
clinic
sampl
occas
test
b
seroconvers
elisa
ifa
neg
antibodi
test
acut
serum
follow
posit
antibodi
test
convalesc
phase
serum
test
parallel
fourfold
greater
rise
antibodi
titr
acut
convalesc
phase
sera
test
parallel
c
viru
isol
isol
cell
cultur
sarscov
specimen
pcr
confirm
use
valid
method
measur
adult
patient
low
viral
load
upper
respiratori
tract
initi
day
ill
pose
diagnost
challeng
lower
respiratori
tract
primari
target
sarscov
infect
probabl
explan
sputum
specimen
appear
higher
diagnost
yield
product
cough
uncommon
sar
patient
earli
phase
ill
sputum
difficult
obtain
children
overal
diagnost
yield
second
week
ill
increas
stool
specimen
also
examin
stool
yield
better
result
respiratori
specimen
improv
rna
extract
specimen
markedli
improv
sensit
convent
rtpcr
assay
modifi
rna
extract
protocol
combin
optimis
realtim
rtpcr
assay
sensit
specif
achiev
first
day
ill
use
npa
prefer
specimen
recent
describ
realtim
nest
pcr
assay
perform
throat
swab
capabl
detect
copi
viral
genom
per
reaction
achiev
much
shorter
turnaround
time
convent
nest
rtpcr
techniqu
realtim
rtpcr
also
appli
plasma
serum
sampl
shown
plasma
serum
sampl
posit
sarscov
rna
first
week
ill
adult
sar
patient
detect
rate
obtain
plasma
eight
paediatr
patient
within
first
week
ill
similarli
suggest
plasma
sarscov
rna
quantif
sensit
potenti
use
earli
diagnost
tool
potenti
advantag
realtim
rtpcr
includ
increas
sensit
reduct
analyt
time
reduct
risk
carri
contamin
avail
quantit
result
diseas
monitor
prognost
purpos
interestingli
despit
milder
clinic
cours
paediatr
patient
signific
differ
plasma
viral
load
observ
plasma
sampl
taken
paediatr
adult
sar
patient
within
first
week
admiss
day
fever
onset
obtain
npa
specimen
regard
hazard
procedur
pose
signific
risk
oper
although
best
specimen
rapid
diagnosi
sar
exclus
pathogen
earli
phase
ill
obviat
need
protect
healthcar
worker
ingeni
method
selfobtain
nasopharyng
specimen
conjunctivaupp
respiratori
tract
irrig
curti
describ
altern
lack
serolog
evid
prior
sarscov
infect
human
suggest
viru
recent
enter
human
popul
presum
anim
reservoir
southern
china
specif
igm
igg
antibodi
appear
respons
sarscov
infect
level
chang
cours
infect
serum
antibodi
test
immunofluoresc
assay
ifa
enzymelink
immunosorb
assay
elisa
develop
diagnos
sar
ifa
test
detect
igm
igg
antibodi
yield
posit
result
case
respect
day
ill
detect
ifa
test
day
indirect
immunofluoresc
test
igg
antibodi
provid
sensit
specif
elisa
test
detect
mixtur
serum
igm
igg
antibodi
respect
posit
second
week
detect
rate
week
decay
curv
suggest
igm
seroposit
lost
week
igg
titr
peak
week
remain
elev
week
antibodi
respons
usual
neg
day
onset
symptom
day
seroconvers
demonstr
sar
patient
despit
corticosteroid
therapi
seroconvers
neg
posit
fourfold
rise
igg
antibodi
titr
indic
recent
infect
detect
antibodi
serum
obtain
day
onset
ill
indic
absenc
sarscov
infect
laboratori
method
exclud
diagnosi
serolog
test
appear
best
method
confirm
sar
posit
rate
rang
igm
antibodi
assay
success
close
diagnost
window
within
first
week
ill
even
patient
seroconvert
earli
util
serolog
confin
retrospect
diagnosi
given
gener
long
lag
time
seroconvers
igg
usual
remain
detect
resolut
ill
durat
persist
protect
neutralis
antibodi
boost
respons
remain
unknown
sarscov
isol
respiratori
secret
blood
stool
inocul
cell
cultur
grow
viru
vero
cell
fetal
rhesu
monkey
kidney
cell
suitabl
support
viral
growth
cytopath
effect
demonstr
day
respect
inocul
cultur
viru
must
identifi
sarscov
test
primarili
rtpcr
assay
major
limit
viral
cultur
sar
low
sensit
one
paediatr
seri
viru
success
isol
npa
cultur
children
neg
cell
cultur
result
like
neg
rtpcr
result
exclud
sar
infect
cell
cultur
also
demand
test
primari
viru
isol
take
long
meaning
earli
diagnosi
furthermor
amplif
viabl
viru
associ
potenti
biohazard
necessit
biosafeti
level
three
contain
culturebas
diagnost
techniqu
unlik
wide
avail
except
anim
inocul
way
show
exist
viabl
sarscov
usual
gold
standard
microbiolog
diagnosi
name
isol
pathogen
limit
applic
sar
global
outbreak
sar
understand
treatment
empir
given
explos
epidem
lifethreaten
infect
multipl
countri
viral
agent
even
identifi
time
plan
let
alon
conduct
welldesign
prospect
clinic
trial
assess
efficaci
treatment
regimen
simpli
propos
regimen
consist
antibiot
ribavirin
corticosteroid
base
initi
anecdot
success
outbreak
studi
adult
patient
subsequ
standard
treatment
protocol
develop
group
physician
hong
kong
includ
antibiot
treatment
communityacquir
pneumonia
caus
usual
atyp
pathogen
ribavirin
broadspectrum
antivir
agent
target
presum
viral
etiolog
sar
immunomodul
agent
form
glucocorticoid
similar
regimen
children
consist
antibiot
ribavirin
without
corticosteroid
use
adult
patient
high
incid
derang
liver
function
leucopaenia
sever
lymphopaenia
thrombocytopaenia
progress
ard
suggest
sever
system
inflammatori
damag
induc
sarscov
pathogenesi
infect
postul
overexuber
immunopatholog
reaction
cytokin
storm
result
unrestrict
viral
replic
earli
stage
diseas
find
consist
cytokin
dysregul
radiolog
chang
multifoc
flit
booplik
featur
progress
ard
histolog
chang
macrophag
infiltr
diffus
alveolar
damag
dramat
clinic
radiolog
improv
highdos
corticosteroid
therapi
viral
load
sar
follow
invert
v
pattern
progress
fall
viral
shed
day
correl
seroconvers
logic
approach
prevent
sever
diseas
restrict
viral
replic
modul
inappropri
immunolog
respons
principl
antivir
agent
prescrib
first
phase
activ
viral
replic
follow
immunomodul
former
fail
patient
affect
immun
hyperactiv
use
ribavirin
adult
children
report
group
investig
worldwid
ribavirin
empir
chosen
sar
broadspectrum
activ
dna
rna
virus
ribavirin
also
known
effect
treatment
fulmin
murin
hepat
caus
anim
coronaviru
murin
hepat
model
ribavirin
exert
immunomodulatori
effect
decreas
releas
proinflammatori
cytokin
macrophag
switch
immun
respons
th
th
respons
howev
later
learnt
ribavirin
demonstr
minim
activ
sarscov
isol
vitro
vitro
test
indic
ribavirin
fail
inhibit
replic
cell
cell
spread
low
drug
concentr
although
inhibitori
activ
demonstr
high
drug
concentr
result
cytotox
effect
undesir
appear
due
low
activ
ribavirin
vitro
inhibitori
concentr
might
achiev
clinic
without
caus
signific
toxic
investig
canada
gener
use
ribavirin
higher
dosag
similar
recommend
treatment
sever
viral
haemorrhag
fever
syndrom
observ
sever
advers
event
adult
patient
booth
et
al
report
patient
elev
hepat
transaminas
level
sinu
bradycardia
haemolysi
haemoglobin
level
declin
least
dl
discontinu
treatment
knowl
et
al
report
patient
haemolyt
anemia
hypocalcemia
hypomagnesaemia
respect
children
appear
toler
ribavirin
much
better
adult
counterpart
solid
clinic
data
demonstr
efficaci
ribavirin
lack
limit
data
suggest
least
adult
dosag
might
effect
caus
sever
advers
reaction
dose
consid
studi
dose
lower
appear
ineffect
randomis
control
trial
involv
use
ribavirin
treatment
sar
conduct
china
zhao
et
al
openlabel
studi
fail
demonstr
efficaci
led
investig
conclud
ribavirin
given
mgd
less
effect
earli
aggress
use
corticosteroid
combin
noninvas
ventilatori
support
nonrandomis
studi
corticosteroid
report
adult
children
seemingli
favour
outcom
term
clinic
radiolog
improv
suggest
combin
use
ribavirin
corticosteroid
might
effect
report
combin
regimen
inconclus
fail
demonstr
obviou
benefit
paediatr
seri
report
leung
et
al
children
laboratoryconfirm
sar
treat
ribavirin
corticosteroid
respect
without
signific
advers
event
patient
recov
seri
report
chiu
et
al
children
receiv
ribavirin
corticosteroid
respect
achiev
similar
outcom
subsequ
confirm
seroconvers
sarscov
report
publish
bitnun
et
al
report
use
ribavirin
without
corticosteroid
children
probabl
sar
virolog
confirm
lack
contrast
zeng
et
al
treat
children
chines
tradit
medicin
antibiot
good
result
children
epidemiolog
link
sar
howev
virolog
data
avail
use
corticosteroid
viral
infect
controversi
potenti
hazard
immunosuppress
agent
corticosteroid
might
promot
viral
replic
enhanc
infect
possibl
caus
rebound
infect
known
acut
viral
respiratori
infect
earlyrespons
cytokin
tumour
necrosi
factor
mediat
lung
injuri
rational
use
corticosteroid
suppress
cytokin
storm
thought
main
factor
account
progress
diseas
use
corticosteroid
possibl
ineffect
antivir
therapi
patient
viral
pneumon
hazard
despit
initi
success
corticosteroid
treatment
sar
report
adult
patient
whose
clinic
cours
complic
fatal
aspergillosi
disturb
even
led
other
recommend
close
laboratori
monitor
aspergillosi
sar
patient
receiv
corticosteroid
retrospect
think
ribavirin
alon
signific
effect
halt
diseas
progress
corticosteroid
probabl
unnecessari
children
develop
moder
sever
hypoxaemia
experi
other
corticosteroid
may
life
save
patient
threaten
impend
acut
respiratori
failur
categor
recommend
treatment
strategi
view
small
number
children
treat
lack
object
evid
control
trial
place
corticosteroid
rescu
therapi
patient
clearli
experienc
failur
support
care
remain
determin
evidencebas
therapeut
approach
sar
exist
although
paper
publish
intern
mention
antivir
treatment
variou
antivir
immunomodul
agent
use
adult
patient
preliminari
success
includ
use
lopinavir
ritonavir
combin
ribavirin
corticosteroid
interferon
plu
corticosteroid
convalesc
plasma
patient
true
role
treatment
children
unknown
knowledg
gener
detail
bioinformat
analysi
sarscov
genom
har
identifi
possibl
target
antivir
therapi
enzymat
protein
viral
replicasetranscriptas
complex
approach
review
davidson
siddel
conclud
econom
effect
way
contain
viru
would
therapeut
use
antivir
agent
block
viral
entri
target
cell
inhibit
intracellular
viral
replic
vitro
studi
highlight
antivir
potenti
sever
compound
includ
recombin
human
interferon
interferon
glycyrrhizin
human
monoclon
antibodi
spike
protein
sarscov
small
interf
rna
understand
pathogenesi
well
clinic
cours
diseas
treatment
evolv
best
treatment
sar
adult
children
remain
unknown
time
side
plan
clinic
trial
diseas
reemerg
increas
vigil
rapid
detect
effect
infect
control
measur
outbreak
sar
seem
less
like
might
never
possibl
therefor
recruit
suffici
number
patient
complet
trial
give
us
earli
answer
adult
risk
factor
sever
ill
advanc
age
high
initi
absolut
neutrophil
count
low
platelet
count
high
initi
peak
lactat
dehydrogenas
level
posit
rtpcr
result
npa
specimen
one
paediatr
seri
identifi
risk
factor
sever
ill
term
requir
oxygen
intens
care
includ
sore
throat
high
neutrophil
count
present
peak
neutrophilia
find
sore
throat
independ
risk
factor
intrigu
may
incident
given
small
number
patient
associ
presenc
sore
throat
detect
sarscov
rtpcr
cultur
npa
specimen
might
correl
higher
viral
load
could
demonstr
shortterm
outcom
sar
among
children
good
comparison
adult
case
fatal
report
need
intens
care
mechan
ventil
respect
adult
chiu
et
al
report
children
requir
oxygen
supplement
none
requir
assist
ventil
leung
et
al
report
oxygen
requir
assist
ventilatori
support
children
figur
oxygen
requir
assist
ventil
two
paediatr
seri
combin
respect
diffus
thin
shed
hair
observ
children
one
seri
gener
month
diseas
onset
condit
selflimit
spontan
recoveri
occur
within
month
consist
acut
telogen
effluvium
secondari
febril
system
ill
critic
care
sever
psycholog
stress
lifethreaten
situat
li
et
al
examin
radiolog
pulmonari
function
outcom
children
month
diagnosi
detect
mild
radiolog
abnorm
hrct
pulmonari
function
test
respect
howev
children
asymptomat
normal
clinic
examin
premorbid
hrct
pulmonari
function
test
result
avail
comparison
contrast
adult
patient
develop
pulmonari
fibrosi
despit
recoveri
primari
ill
psycholog
impact
separ
isol
intimid
hospit
environ
bereav
famili
disintegr
follow
death
close
adult
famili
member
children
recov
sar
immens
howev
children
appear
resili
adult
psycholog
adjust
sar
seriou
psycholog
sequela
evid
month
discharg
continu
monitor
delay
onset
psycholog
problem
children
essenti
children
recov
acut
ill
monitor
possibl
continu
viral
shed
develop
pulmonari
sequela
postvir
complic
eg
chronic
fatigu
well
longterm
complic
highdos
corticosteroid
therapi
children
suscept
infect
sarscov
despit
milder
clinic
pictur
good
shortto
mediumterm
outcom
avail
reliabl
earli
diagnost
techniqu
treatment
remain
controversi
longterm
outcom
sar
children
remain
unknown
still
enorm
gap
knowledg
sar
much
work
need
done
urgent
sar
larg
atyp
pneumonia
minim
extrapulmonari
manifest
apart
diarrhoea
clinic
pictur
sar
milder
children
teenag
may
develop
sever
ill
resembl
adult
clinic
radiolog
laboratori
featur
sar
nonspecif
epidemiolog
link
import
clue
diagnosi
outbreak
situat
refin
rtpcr
assay
achiev
sensit
earli
diagnosi
sar
first
day
ill
npa
specimen
prefer
specimen
rtpcr
assay
first
week
ill
npa
stool
specimen
test
second
week
neg
rtpcr
result
exclud
diagnosi
absenc
seroconvers
beyond
day
diseas
onset
gener
exclud
diagnosi
apart
support
treatment
includ
oxygen
therapi
assist
ventil
treatment
modal
remain
unproven
molecular
biolog
sarscov
mechan
genom
express
pathogenesi
sarscov
infect
natur
histori
full
spectrum
sarscov
infect
improv
earli
diagnost
techniqu
gold
standard
diagnosi
novel
therapi
vaccin
longitudin
followup
longterm
outcom
persist
protect
immun
reinfect
